|
🐜
|
Utility of serum antibodies in determining clinical course in pediatric Crohn's disease.
7 auth.
B. Désir,
D. Amre,
Shou-En Lu,
P. Ohman-Strickland,
M. Dubinsky,
R. Fisher,
...
E. Seidman
|
6 |
2004 |
6
🐜
|
|
🐜
|
Hematological Adverse Events with Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: A Systematic Review with Meta-Analysis
8 auth.
Olivia Kronick,
Xinyu Chen,
Nidhi Mehra,
Armon Varmeziar,
R. Fisher,
David Kartchner,
...
V. Kota,
Cassie S. Mitchell
|
2 |
2023 |
2
🐜
|
|
🐬
|
O0072 6‐MMP/6‐TG METABOLITE LEVELS & THEIR RATIO GUIDE THIOPURINE TREATMENT IN ULCERATIVE COLITIS
E. Seidman,
Y. Théorêt,
R. Fisher,
J. Seidman,
D. Amre
|
1 |
2004 |
1
🐬
|
|
🐢
|
DP02 (P30) Declining staff numbers and increasing workload: is there a solution?
Charlotte Wolfe,
Rebecca Phillips,
Dhruvkumar Laheru,
R. Fisher
|
1 |
2023 |
1
🐢
|
|
🐜
|
DP11: Methotrexate‐induced cutaneous lymphoproliferative disorders presenting as Epstein–Barr virus‐positive mucocutaneous ulcer mimicking high‐grade lymphoma
8 auth.
P. Macklin,
R. Fisher,
R. Matin,
E. Ieremia,
Maneh Farazmand,
J. Ferguson,
...
R. Green,
J. Goodlad
|
0 |
2022 |
0
🐜
|
|
🐜
|
DP12: An 11‐year mystery
8 auth.
P. Macklin,
R. Fisher,
R. Matin,
E. Ieremia,
Maneh Farazmand,
J. Ferguson,
...
R. Green,
J. Goodlad
|
0 |
2022 |
0
🐜
|
